140 related articles for article (PubMed ID: 10756540)
1. Soft cannabinoid analogues as potential anti-glaucoma agents.
Buchwald A; Browne CE; Wu WM; Ji F; Bodor N
Pharmazie; 2000 Mar; 55(3):196-201. PubMed ID: 10756540
[TBL] [Abstract][Full Text] [Related]
2. Soft cannabinoid analogues as potential anti-glaucoma agents.
Buchwald A; Derendorf H; Ji F; Nagaraja NY; Wu WM; Bodor N
Pharmazie; 2002 Feb; 57(2):108-14. PubMed ID: 11878185
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic agents derived from the cannabinoid nucleus.
Pars HG; Howes JF
Adv Drug Res; 1977; 11():97-189. PubMed ID: 24325
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
ElSohly MA; Harland EC; Benigni DA; Waller CW
Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities of applying cannabinoids' in the treatment of glaucoma].
Nadolska K; Goś R
Klin Oczna; 2008; 110(7-9):314-7. PubMed ID: 19112869
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
[TBL] [Abstract][Full Text] [Related]
8. The effects of prostacyclin and its stable analog on intraocular pressure.
Hoyng PF; Groeneboer MC
Prog Clin Biol Res; 1989; 312():369-78. PubMed ID: 2508128
[TBL] [Abstract][Full Text] [Related]
9. Use of cannabinoid derivatives in glaucoma.
Newell FW; Jay WM; Sternberg P
Trans Ophthalmol Soc U K (1962); 1979 Jul; 99(2):269-71. PubMed ID: 298426
[No Abstract] [Full Text] [Related]
10. [Cannabis and cannabinoids. Possibilities of their therapeutic use].
Heim ME
Fortschr Med; 1982 Mar; 100(9):343-6. PubMed ID: 7076098
[TBL] [Abstract][Full Text] [Related]
11. New approaches to antiglaucoma therapy.
Sugrue MF
J Med Chem; 1997 Aug; 40(18):2793-809. PubMed ID: 9288160
[No Abstract] [Full Text] [Related]
12. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma.
Volopich S; Mosing M; Auer U; Nell B
Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in the treatment of glaucoma.
Järvinen T; Pate DW; Laine K
Pharmacol Ther; 2002 Aug; 95(2):203-20. PubMed ID: 12182967
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
17. Prostanoids in the therapy of glaucoma.
Ishida N; Odani-Kawabata N; Shimazaki A; Hara H
Cardiovasc Drug Rev; 2006; 24(1):1-10. PubMed ID: 16939629
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Oculohypotensive effects of foeniculum vulgare in experimental models of glaucoma.
Agarwal R; Gupta SK; Agrawal SS; Srivastava S; Saxena R
Indian J Physiol Pharmacol; 2008; 52(1):77-83. PubMed ID: 18831355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
